Procaps Group S.A.
NASDAQ:PROC
1.78 (USD) • At close November 1, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Procaps Group S.A. |
Symbool | PROC |
Munteenheid | USD |
Prijs | 1.785 |
Beurswaarde | 201,390,840 |
Dividendpercentage | 0% |
52-weken bereik | 1.68 - 4.95 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Ruben Minski |
Website | https://www.procapsgroup.com |
An error occurred while fetching data.
Over Procaps Group S.A.
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)